Surgical Science Sweden

Surgical Science Sweden FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Surgical Science Sweden (SUS.ST) as of Nov 3, 2026 is 101.94 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 68.13 % — a change of 49.62% (higher).

FCF Conversion

101.94 %

YoY

49.62%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Surgical Science Sweden is 2025 101.94 % . FCF Conversion Rate (FCF/EBITDA) of Surgical Science Sweden was 2024 68.13 % . It decreases by 49.62% higher compared to the previous year.

The Surgical Science Sweden FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
38.92 SEK
Jan 1, 2019
367.42 SEK
Jan 1, 2020
93.11 SEK
Jan 1, 2021
28.65 SEK
Jan 1, 2022
50.51 SEK
Jan 1, 2023
82.99 SEK
Jan 1, 2024
68.13 SEK
Jan 1, 2025
101.94 SEK
The Surgical Science Sweden FCF Conversion history
YEARFCF ConversionYoY
101.94 %+49.62%
68.13 %-17.90%
82.99 %+64.31%
50.51 %+76.32%
28.65 %-69.24%
93.11 %-74.66%
367.42 %+843.92%
38.92 %-78.97%
185.08 %+259.26%
51.52 %-203.03%
-50.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Surgical Science Sweden Stock analysis

What does Surgical Science Sweden do? Surgical Science Sweden AB is a Swedish company specializing in the development and manufacturing of medical simulators for training professionals in the medical industry. The company was founded in 1999 by a team of doctors, engineers, and scientists and is headquartered in Gothenburg. Since then, the company has constantly expanded and now has several branches around the world, including in the USA, Germany, and Hong Kong. Due to its innovative products and high-quality standards, the company is globally recognized and has received numerous awards. Surgical Science Sweden AB offers a wide range of simulators for various medical disciplines, including surgery, anesthesia, obstetrics, and pediatrics. They offer both hardware and software-based solutions that allow trainees to practice complex procedures and interventions in a safe environment. The company's business model is based on the belief that simulation is crucial for the training of medical professionals to ensure the highest quality and safety for patients. By simulating realistic situations, trainees can gain valuable experience before working in the real practice. Surgical Science Sweden AB has a range of products targeting various areas of medical education. One of their most well-known simulators is the LaparoSculptor, which was specifically developed for training in minimally invasive surgery. The simulator can perform various procedures such as gallbladder and hernia operations, offering both physical and virtual options. Another product is the ObstetricSim, a simulator for obstetric training. The simulator fully simulates the conditions of a normal birth, including the stages of labor and delivery. It also includes rare complications such as shoulder dystocia and umbilical cord prolapse. Surgical Science Sweden AB has also developed simulators focusing on the training of anesthesiologists. The simulator in this area is the ANTS (Anesthesia Simulator), which trains trainees in the proper use of anesthetics, patient observation, and managing emergencies during anesthesia issues. In addition to developing hardware and software solutions, the company also focuses on continuous improvement and development of its products. Surgical Science Sweden AB works closely with leading medical specialists to ensure that the simulator meets the latest requirements and best practices. The company is also willing to rent or sell the simulators and its expertise to medical institutions, providing a broader audience with the opportunity to benefit from the technology. In conclusion, Surgical Science Sweden AB makes a significant contribution to the training of medical professionals and thereby contributes to improving patient health worldwide with its innovative and high-quality simulators. By combining the latest technology, industry expertise, and a constant focus on customer needs, the company continuously strives for excellence and innovation. Surgical Science Sweden is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Surgical Science Sweden stock

FCF Conversion Rate (FCF/EBITDA) of Surgical Science Sweden is 101.94 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Surgical Science Sweden changed from 68.13 % to 101.94 %, representing a 49.62% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Surgical Science Sweden since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Surgical Science Sweden with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Surgical Science Sweden

All Key Metrics — Surgical Science Sweden